Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roger J. Brüggeman"'
Autor:
Intan M.W. Dewi, Cristina Cunha, Martin Jaeger, Mark S. Gresnigt, Marina E. Gkountzinopoulou, Fadel M. Garishah, Cláudio Duarte-Oliveira, Cláudia F. Campos, Lore Vanderbeke, Agustin Resendiz Sharpe, Roger J. Brüggemann, Paul E. Verweij, Katrien Lagrou, Greetje Vande Velde, Quirijn de Mast, Leo A.B. Joosten, Mihai G. Netea, Andre J.A.M. van der Ven, Joost Wauters, Agostinho Carvalho, Frank L. van de Veerdonk
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 5, Pp 100289- (2021)
Summary: Influenza-associated pulmonary aspergillosis (IAPA) has been reported increasingly since the advent of use of neuraminidase (NA) inhibitors following the 2009 influenza pandemic. We hypothesize that blocking host NA modulates the immune resp
Externí odkaz:
https://doaj.org/article/6db0b061daa24bc6ab6079fafd1b44cf
Autor:
Ruth Van Daele, Joost Wauters, Pieter De Cock, Franky Buyle, John Leys, Pieter Van Brantegem, Matthias Gijsen, Pieter Annaert, Yves Debaveye, Katrien Lagrou, Willy E. Peetermans, Roger J. Brüggemann, Isabel Spriet
Publikováno v:
Antibiotics, Vol 10, Iss 9, p 1112 (2021)
Background: Voriconazole is an antifungal drug used as one of the first-line treatments for invasive aspergillosis. This drug is extensively metabolized, predominantly via cytochrome P450 enzymes. An interaction between flucloxacillin and voriconazol
Externí odkaz:
https://doaj.org/article/d518ce7c695b4b679e9787766d2dad50
Autor:
Ruth Van Daele, Joost Wauters, Katrien Lagrou, Raphaël Denooz, Marie-Pierre Hayette, Matthias Gijsen, Roger J. Brüggemann, Yves Debaveye, Isabel Spriet
Publikováno v:
Microorganisms, Vol 9, Iss 10, p 2068 (2021)
Background: Fluconazole is one of the oldest antifungal drugs. Previous studies have raised concerns considering variability in exposure and inadequate target attainment in critically ill patients. The current study aims to define variability and tar
Externí odkaz:
https://doaj.org/article/555544e255df4869b0a45eb0144d8735
Autor:
Didi Bury, Corline E.J. Parmentier, Wim J.E. Tissing, Rob Pieters, Louis J. Bont, Roger J. Brüggemann, Tom F.W. Wolfs
Publikováno v:
EJC Paediatric Oncology, Vol 3, Iss , Pp 100143- (2024)
Background: Childhood acute lymphoblastic leukaemia (ALL) cure rates have improved, but invasive mould disease (IMD) remains a life-threatening complication. Here, we evaluate the epidemiology, clinical presentation, treatment and outcome of IMD in p
Externí odkaz:
https://doaj.org/article/5bc0c005081d4b1286e1488144ede9b5
Autor:
Frank L. van de Veerdonk, Eva Kolwijck, Pieter P. A. Lestrade, Caspar J. Hodiamont, Bart J. A. Rijnders, Judith van Paassen, Pieter-Jan Haas, Claudy Oliveira dos Santos, Greetje A. Kampinga, Dennis C. J. J. Bergmans, Karin van Dijk, Anton F. J. de Haan, Jaap van Dissel, Hans G. van der Hoeven, Paul E. Verweij, Janette C. Rahamat-Langendoen, Bart-Jan Kullberg, Mihai G. Netea, Roger J. Brüggeman, Astrid W. Hoedemaekers, Willem J. G. Melchers, Wieke Freudenburg, Nienke Roescher, W. Joost Wiersinga, Charlotte H. S. B. van den Berg, Alieke G. Vonk, Carla van Tienen, Ben van der Hoven, Martha T. van der Beek, Lennie P.G. Derde, Coretta van Leer, Heleen Aardema, Astrid Oude Lashof, C. Wim Ang
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 196, 524-527
American Journal of Respiratory and Critical Care Medicine, 196(4), 524-527. AMER THORACIC SOC
American Journal of Respiratory and Critical Care Medicine, 196(4), 524-527. American Thoracic Society
Van De Veerdonk, F L, Kolwijck, E, Lestrade, P P A, Hodiamont, C J, Rijnders, B J A, Van Paassen, J, Haas, P J, Dos Santos, C O, Kampinga, G A, Bergmans, D C J J, Van Dijk, K, De Haan, A F J, Van Dissel, J, Van Der Hoeven, H G & Verweij, P E 2017, ' Influenza-associated aspergillosis in critically ill patients ', American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 4, pp. 524-527 . https://doi.org/10.1164/rccm.201612-2540LE
American Journal of Respiratory and Critical Care Medicine, 196, 4, pp. 524-527
American Journal of Respiratory and Critical Care Medicine, 196(4), 524-527
American journal of respiratory and critical care medicine, 196(4), 524-527. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine, 196(4), 524-527. AMER THORACIC SOC
American Journal of Respiratory and Critical Care Medicine, 196(4), 524-527. American Thoracic Society
Van De Veerdonk, F L, Kolwijck, E, Lestrade, P P A, Hodiamont, C J, Rijnders, B J A, Van Paassen, J, Haas, P J, Dos Santos, C O, Kampinga, G A, Bergmans, D C J J, Van Dijk, K, De Haan, A F J, Van Dissel, J, Van Der Hoeven, H G & Verweij, P E 2017, ' Influenza-associated aspergillosis in critically ill patients ', American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 4, pp. 524-527 . https://doi.org/10.1164/rccm.201612-2540LE
American Journal of Respiratory and Critical Care Medicine, 196, 4, pp. 524-527
American Journal of Respiratory and Critical Care Medicine, 196(4), 524-527
American journal of respiratory and critical care medicine, 196(4), 524-527. American Thoracic Society
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c8d3b6e3a1413d301f1d4b7a3afa64
https://doi.org/10.1164/rccm.201612-2540le
https://doi.org/10.1164/rccm.201612-2540le
Publikováno v:
Journal of Fungi, Vol 8, Iss 1, p 18 (2021)
Invasive fungal infections (IFI) are a common infection-related cause of death in immunocompromised patients. Approximately 10 million people are at risk of developing invasive aspergillosis annually. Detailed study of the pharmacokinetics (PK) and p
Externí odkaz:
https://doaj.org/article/52e90e94037844df8583b8a5ea2e2759